Clearmind Medicine

How veteran care is shaping the future of mental health. psychologytoday.com/ca/blog/psyche… #PsychologyToday #therapeuticalliance #veterans #CMND #MEAI

“We are very encouraged by the successful completion of treatment and follow-up for these 18 participants, alongside the rapid addition of four more patients at our Tel Aviv center,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine. clearmind-cmnd.short.gy/successful-com… $CMND

The Faces of Clearmind: Meet Our Scientific Advisory Board Prof. Wim van den Brink MD, PhD, University of Amsterdam, The Netherlands Prof. Michael Davidson MD, Israeli Medical Centre for Alzheimer's, Israel clearmindmedicine.com/our-team #CMND #MEAI #facesofclearmind #executive #pharmaceutical #biotechnology #alcoholusedisorder #scientific #scientificadvisoryboard #universityofamsterdam $CMND

On World Health Day, we recognize the importance of advancing science that can improve mental health outcomes. Continued research and innovation are essential to better understand and address complex conditions such as addiction. At Clearmind Medicine, we are committed to advancing next-generation solutions for alcohol use disorder and mental health conditions. #WorldHealthDay #WorldHealthDay2026 #MentalHealth #SDGs #Biotech #Neuroscience #ClinicalResearch #Innovation #Addiction #AUD #Neuroplastogen #CMND #MEAI #AUD #Science #Innovation #Addiction $CMND

If you missed it. 1) Clearmind Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial clearmind-cmnd.short.gy/successful-com… 2) Clearmind Files Patent Application in India for Next-Gen Psychedelic Compounds clearmind-cmnd.short.gy/next-gen-india 3) Publication of Six Patents in Hong Kong clearmind-cmnd.short.gy/hongkong 4) Publication of International Patent for Novel Therapy Targeting Weight Loss clearmind-cmnd.short.gy/patent-weightl… 5) Receive Press Releases: clearmind-cmnd.short.gy/join-newsJoin #MEAI #CMND #psychologytoday #newsletter #secondcohort #clinicaltrial #innovation #biotechinnovation #leadership #alcoholusedisorder #cohort #weightloss #fattyliver #johnshopkins #yale #CMND100 #patent #depression $CMND

The Interdisciplinary Conference on Psychedelic Research is coming back to Haarlem, the Netherlands, on June 4–6, for its seventh edition! As Europe’s premier conference on psychedelic science and therapy, ICPR 2026 brings together an interdisciplinary community and features 100+ speakers across a programme focused on rigorous science, critical perspectives, and innovative psychedelic therapies. Use code CM10 to claim a 10% community discount on tickets (This partner code is limited to the first 10 registrations): icpr-conference.com/tickets. @OPEN_fndn

The Faces of Clearmind: Meet Our Scientific Advisory Board Prof. Christian Schütz MD, PhD, University of British Columbia, Canada Prof. Gabriele Fischer MD, PhD, Medical University Vienna, Austria Prof. Alon Friedman MD, PhD, Dalhousie University, Canada clearmindmedicine.com/our-team #CMND #MEAI #facesofclearmind #executive #pharmaceutical #biotechnology #alcoholusedisorder #scientific #scientificadvisoryboard #harvard #yaleuniversity #universityofpennsylvania #medical #leadership $CMND

The patent protects novel new compounds designed to overcome the limitations of classical psychedelics, offering potentially safer, more effective, and scalable treatment options for underserved mental health conditions and addictive disorders. clearmind-cmnd.short.gy/next-gen-india $CMND

Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder clearmindmedicine.com/news-release/c… #CMND #MEAI #ClinicalTrial #AUD #alcoholusedisorder #treatment #CMND100 #innovation #biotechnology $CMND

If you missed it. 1) Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders clearmind-cmnd.short.gy/next-gen-india 2) Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial clearmind-cmnd.short.gy/FDA-CMND100 3) Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies clearmind-cmnd.short.gy/hongkong 4) Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease clearmind-cmnd.short.gy/patent-weightl… 5) Receive Press Releases to Your Inbox: clearmind-cmnd.short.gy/join-newsJoin #MEAI #CMND #psychologytoday #newsletter #secondcohort #clinicaltrial #innovation #biotechinnovation #leadership #alcoholusedisorder #cohort #weightloss #fattyliver #johnshopkins #yale #CMND100 #patent #depression $CMND

The patent application, filed with the Indian Patent Office, forms part of the Company’s expanding global intellectual property portfolio and builds upon its exclusive worldwide licensing agreement with @yissumhuji Yissum Research Development Company of the Hebrew University of Jerusalem. clearmind-cmnd.short.gy/next-gen-india #CMND #MEAI #BiotechInnovation #IntellectualProperty #DrugDevelopment #GlobalExpansion #India #MentalHealthInnovation #LifeSciences #StrategicPartnerships $CMND

Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders clearmindmedicine.com/news-release/c… #CMND #MEAI #India #NextGen #PsychedelicScience #HealthDisorders #MentalHealth

Patients at the prestigious U.S. institutions – Yale University and Johns Hopkins University – continue to progress successfully through their treatment protocol, demonstrating continued safety and tolerability with no serious adverse events reported to date. clearmind-cmnd.short.gy/FDA-CMND100 #CMND #MEAI #FDA #JohnsHopkins #YaleUniversity #safety

The Faces of Clearmind: Meet Our Scientific Advisory Board Prof. Fatima Cody Stanford MD, MPH, MPA, Harvard Medical School, US Prof. Henry R. Kranzler MD, PhD, University of Pennsylvania, US Prof. John Krystal MD, Yale University, US clearmindmedicine.com/our-team #CMND #MEAI #facesofclearmind #executive #pharmaceutical #biotechnology #alcoholusedisorder #scientific #scientificadvisoryboard #harvard #yaleuniversity #universityofpennsylvania #medical #leadership $CMND

"By combining our MEAI platform with PEA from our partners at NeuroThera Labs, we are positioning ourselves to address the escalating demand for effective, tolerable and safe treatments in the obesity and liver health space." clearmind-cmnd.short.gy/patent-weightl… $CMND #MEAI #GLP1

Building a Therapeutic Revolution: Veterans Lead the Way How veteran care is shaping the future of mental health. by Dr. Adi Zuloff-Shani PhD psychologytoday.com/ca/blog/psyche… "Post-traumatic stress disorder (PTSD), major depressive disorder, substance use disorders, and traumatic brain injury remain among the most complex and high-burden psychiatric conditions. Remission rates remain suboptimal in treatment-resistant populations, and relapse is common. For U.S. veterans, the urgency is particularly acute." #PsychologyToday #PTSD #USVeterans #Veterans #Depression #TBI #psychiatric #CMND $CMND

If you missed it. 1) Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder clearmind-cmnd.short.gy/FDA-CMND100 2) Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies clearmind-cmnd.short.gy/hongkong 3) Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease: clearmind-cmnd.short.gy/patent-weightl… 4) Receive Press Releases to Your Inbox: clearmind-cmnd.short.gy/join-newsJoin #MEAI #CMND #psychologytoday #newsletter #secondcohort #clinicaltrial #innovation #biotechinnovation #leadership #alcoholusedisorder #cohort #weightloss #fattyliver #johnshopkins #yale #CMND100 #patent #depression $CMND

Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder clearmindmedicine.com/news-release/c… #CMND #MEAI #FDA #CMND100 #treatment #AUD #clinicaltrial #yaleuniversity #johnshopkins $CMND

Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies clearmindmedicine.com/news-release/c… #CMND #MEAI #patents #hongkong #psychedelicbiotech #neuroscience $CMND

This novel therapy integrates Clearmind’s proprietary 5-methoxy-2-aminoindane (MEAI) with Palmitoylethanolamide (PEA), provided through its collaboration with NeuroThera Labs Inc., a subsidiary of @SciSparc Ltd. clearmind-cmnd.short.gy/patent-weightl… #CMND #MEAI #obesity #GLP1 $CMND